DCs are antigen-presenting cells that play an important role in initiating anti-tumor immune responses, on account of their ability to activate tumor-specific CD8+ cytotoxic T cells, which can directly kill tumor cells and mediate tumor regression (1–5). Here, CD8A is linked to neoplasm.